Sleep-promoting effects of threonine link amino acid metabolism in <i>Drosophila</i> neuron to GABAergic control of sleep drive.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31313987.
- Also identified by DOI 10.7554/eLife.40593 and PMC identifier 6636906.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Emerging evidence indicates the role of amino acid metabolism in sleep regulation. Here we demonstrate sleep-promoting effects of dietary threonine (SPET) in <i>Drosophila</i>. Dietary threonine markedly increased daily sleep amount and decreased the latency to sleep onset in a dose-dependent manner. High levels of synaptic GABA or pharmacological activation of metabotropic GABA receptors (GABA<sub>B</sub>-R) suppressed SPET. By contrast, synaptic blockade of GABAergic neurons or transgenic depletion of GABA<sub>B</sub>-R in the ellipsoid body R2 neurons enhanced sleep drive non-additively with SPET. Dietary threonine reduced GABA levels, weakened metabotropic GABA responses in R2 neurons, and ameliorated memory deficits in plasticity mutants. Moreover, genetic elevation of neuronal threonine levels was sufficient for facilitating sleep onset. Taken together, these data define threonine as a physiologically relevant, sleep-promoting molecule that may intimately link neuronal metabolism of amino acids to GABAergic control of sleep drive via the neuronal substrate of sleep homeostasis. This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that all the issues have been addressed (see decision letter).
Medical subject headings
- Drosophila
- GABAergic Neurons
- Sleep
- Sleep Aids, Pharmaceutical
- Threonine